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ABSTRACT
Comparison of Antibacterial Activity of
Ozonated Olive Oil and Chlorhexidine Gluconate
by
Changmin Lee
Master of Science, Graduate Program in Periodontics
Loma Linda University, December 2017
Dr. Tord Lundgren, Chairperson
Aim: The aim of this in vitro disk diffusion susceptibility test is to compare the
antibacterial activity of ozonated olive oil (OzOO) with chlorhexidine gluconate
(CHX) against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter
Actinomycetemcomitans.
Materials and Methods: The antibacterial activity of two antiseptics, OzOO and
CHX, and, two controls, olive oil and normal saline was assessed by disk diffusion
susceptibility test. For disk diffusion susceptibility test, two periodontal pathogens,
20 petri dishes for P. gingivalis and 18 petri dishes for A. actinomycetemcomitans,
were used. To assess the antibacterial activity, the diameters of the growth
inhibition zone were measured with a caliper.
Results: The diameters of the growth inhibition zone against P. gingivalis were 31.4
± 5.05 mm for OzOO and 20.9 ± 1.19 mm for CHX (p<0.001). The diameters of the
growth inhibition zone against A. actinomycetemcomitans were 25.9 ± 1.69 mm for
OzOO and 18.4 ± 1.55 mm for CHX (p<0.001). All the measured diameters for olive
oil and normal saline against both periodontal pathogens were 6 mm, with no sign
of the growth inhibition.
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Conclusion: The antibacterial activity of OzOO against P. gingivalis and A.
actinomycetemcomitans is superior to that of CHX.
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CHAPTER ONE
INTRODUCTION AND REVIEW OF THE LITERATURE
In the mouth, teeth provide hard and non-shedding surfaces for the
development of bacterial deposits. This bacterial colonization, dental plaque, is
considered as the primary cause of periodontal disease and caries. Hundreds of
different bacterial species are found in dental plaque. Among these bacteria, three
red complex bacteria, Porphyromonas gingivalis, Treponema denticola and
Tannnerella forsythia and Aggregatibacter actinomycetemcomitnas are believed to
be the major etiologic elements for the development of periodontal disease (1).
These species have been recognized as the important periodontal pathogens in
many scientific articles and also in the consensus report from the World Workshop
of Periodontology (2).
The primary goal in the treatment of periodontal disease is the anti-infective
therapy to eliminate oral pathogens, stop disease progression and maintain the
long-term periodontal stability. Therapeutic regimes to achieve these aims include
various combinations of oral hygiene techniques, scaling and root planing (SRP) as
an initial non-surgical treatment, surgical elimination of periodontal pockets and
anatomical defects, and, correction of inadequate dental restorations which aid
bacterial retention and interfere with plaque removal.
The bacterial etiology of periodontal disease (3-5) and the hypothesis that
specific bacteria are involved (6) have intensified the interest of using anti-bacterial
agents as a complement to non-surgical and surgical periodontal therapy (7, 8).
Among anti-bacterial agents, chlorhexidine gluconate (CHX) is often used as the
1

local vehicle. It has shown to inhibit the growth of various bacterial species isolated
from subgingival plaque (9). Clinically, it has been widely used, as the antiseptic
agent in the mouthrinse. Clinical trials also have been performed with daily use of
CHX mouthrinse for up to 2 years (10, 11). In addition, a CHX chip product is also
available as an adjunct to SRP (12, 13).
However, the prolonged use of CHX may cause epithelial desquamation,
tooth staining, altered taste sensation, impairment of wound healing and reduced
attachment of fibroblasts to root surfaces (14, 15).
Ozone is currently discussed as a possible alternative oral antiseptic agent
with fewer side effects. Ozone is bactericidal, anti-viral and anti-fungal. When ozone
is infused into unsaturated oil such as olive oil, it becomes ozonated olive oil (OzOO)
and releases hydrogen peroxide. OzOO has been reported to be used topically for
the treatment of war wounds, gingivitis, abscess, anaerobic and herpetic infections,
fungal disease, trophic ulcers and burns, anal fissures, furunculosis and vulvovaginitis (16, 17). It has been hypothesized that the action of ozonated oil on wound
healing may be connected in part to its antimicrobial effect but also to its ability to
promote some growth factors, activate local anti-oxidant mechanisms and promote
tissue repair (18).
Clinical effects of topical application of OzOO have also been reported. In one
study, the efficacy of OzOO on free gingival graft surgical wounds was evaluated. A
significant improvement in epithelial healing and gingival health after topical
application to the surgical sites was reported (19). Also, the efficacy of OzOO as a
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mono-therapy and an adjunct to SRP in the treatment of chronic periodontitis
improved the periodontal conditions (20).
In another study, OzOO showed significantly greater growth inhibition
against P. gingivalis and Staphylococcus aureus than 0.2% CHX, using a disk diffusion
susceptibility test (21). However, the evidence of OzOO as an alternative to CHX is
still lacking. To evaluate the antibacterial activity for both chronic and aggressive
periodontitis, the effect of OzOO and CHX on red complex bacteria and A.
actinomycetemcomitans should be assessed. In addition, the effect of another
commercially available OzOO and CHX should be assessed.
The aim of this in vitro disk diffusion susceptibility test is to compare the
antibacterial activity of a commercially available OzOO with CHX against two
periodontal pathogens, P. gingivalis and A. actinomycetemcomitans. The null
hypothesis is that there is no significant difference of the antibacterial activity
between two antiseptics, OzOO and CHX, against two periodontal pathogens, P.
gingivalis and A. actinomycetemcomitans.
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CHAPTER TWO
MATERIAL AND METHODS
Microbial Species
Freeze-dried bacteria were obtained from Division of Microbiology and
Molecular Genetics, School of Medicine, Loma Linda University. The bacteria strains
were: P. gingivalis ATCC® 33277TM and A. actinomycetemcomitans ATCC® 33384 TM.

Culture Conditions
Frozen and isolated P. gingivalis was inoculated into the culture tube
containing Brain-Heart Infusion (BHI) medium consisted of 18.5 g dehydrated BHI,
5 ug/ml hemin, 100 ul vitamin K, 2.5 g yeast extract and 0.5 g DL-cystein. Then the
tube was incubated at 37˚c under anaerobic conditions (5% CO2, 10% H2, 85% N2)
for 24 hours.
Frozen and isolated A. actinomycetemcomitans was also inoculated in the
culture tube having same medium and incubated at 37˚c under the same anaerobic
conditions for 24 hours.

Antiseptics
The following antiseptics were tested: OzOO (PurO3® , Promolife Inc.,
Fayetteville, AR, USA) with a peroxide value of 224 meq/Kg (Figure 1), and, 0.12%
CHX (Peridex® , 3M ESPE, St. Paul, MN, USA).

4

Figure 1. Ozonated olive oil (PurO3® , Promolife Inc., Fayetteville, AR, USA)

In addition to these two antiseptics, two control groups were tested: Olive oil
(Promolife Inc., Fayetteville, AR, USA), and, normal saline (0.9% Sodium Chloride
Irrigation, USP® , Baxter, Irvine, CA, USA).

Disk Diffusion Susceptibility Test
6 mm-diameter sterile disks (Antibiotic Sensitivity Disks, Blank, Sterile® ,
Carolina Biological Supply Company, Burlington, NC, USA) (Figure 2) were prepared
and impregnated with two test groups, OzOO and CHX, and two control groups, olive
oil and normal saline. 50 ul of each group was impregnated into each disk using a
micropipette. Semi solid-liquid OzOO was warmed up in the heating bath circulator
to be converted into liquid immediately prior to impregnation for ease of
application. Then, all the sterile disks were kept for 24 hours for fully impregnation
in room temperature.
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Figure 2. 6 mm-diameter sterile disk (Antibiotic Sensitivity Disks,
Blank, Sterile® , Carolina Biolgical Supply Company, Burlington, NC,
USA)

Microbial suspensions, P. gingivalis and A. actinomycetemcomitans, were
aseptically spread on the 20 petri dishes for P. gingivalis and 18 petri dishes for A.
actinomycetemcomitans, respectively. Each dish contained BHI agar consisted of
18.5 g dehydrated BHI, 5 ug/ml hemin, 100 ul vitamin K, 2.5 g yeast extract, 0.5 g
DL-cystein and 10 g bacto agar.
Previously impregnated sterile disks were placed onto BHI agar surface. In
one petri dish, four disks impregnated with each group, OzOO, CHX, olive oil and
normal saline respectively, were placed onto each quadrant. Overall, 144 total
sterile disks were used for this in vitro study.
All the petri dishes spread with P. gingivalis and A. actinomycetemcomitans
respectively with four disks were then incubated at 37˚c under anaerobic conditions
(5% CO2, 10% H2, 85% N2) for 48 hours.

6

The antibacterial activity was assessed by measuring the diameters of the
growth inhibition zone surrounding each disk with a caliper in millimeters, after 48
hours of incubation period. When the shape of the growth inhibition zone
surrounding disks was not a circle, the shortest and longest diameters were
measured and the mean measurement was calculated as a representative diameter.

Statistical Analysis
The diameters of the growth inhibition zone of four groups against for each
microbial suspension, P. gingivalis and A. actinomycetemcomitans were compared
using Kruskal-Wallis test at alpha level of 0.05. Since there was no effect of olive oil
and normal saline, a paired t-test was used to compare the effect of OzOO and CHX
on each microbial suspension, P. gingivalis and A. actinomycetemcomitans at alpha
level of 0.05.
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CHAPTER THREE
RESULTS
The diameters of the growth inhibition zone of all groups against P. gingivalis
and A. actinomycetemcomitans were measured. The mean and standard deviation
(SD) of all petri dishes are presented in Tables 1, 2 and 3.
The mean ± SD diameters of the growth inhibition zone against P. gingivalis
were 31.4 ± 5.05 mm for OzOO, and, 20.9 ± 1.19 mm for CHX (Figure 3 and 4). The
mean ± SD diameters of the growth inhibition zone against A.
actinomycetemcomitans for OzOO and CHX were 25.9 ± 1.69 mm and 18.4 ± 1.55
mm respectively (Figure 3-8). All the measured diameters for olive oil and normal
saline against both microbial suspensions were 6 mm, same as the diameter of a
sterile disk, with no sign of the growth inhibition (Figure 5-8).
While the growth inhibition zone for CHX was a full circle shape in all petri
dishes, it was not always for OzOO. In addition, the growth inhibition zone for OzOO
and CHX against A. actinomycetemcomitans was fully and/or partially blurred
(Figure 7, 8). The growth inhibition zone for OzOO was not fully clear but blurred,
and the degree of blurring varied between petri dishes. The growth inhibition zone
for CHX was a clear circle with a blurred edge.
Kruskal-Wallis test showed a significant difference of the growth inhibition
zone between the groups. A paired t-test was conducted to compare the growth
inhibition zone for OzOO and CHX against both P. gingivalis and A.
actinomycetemcomitans. For both microbial suspensions, there was a significant
difference between two groups with p<0.001 (Table 4).
8

Table 1. Diameters in millimeters of the growth inhibition zone for OzOO, CHX,
olive oil and normal saline against P. gingivalis
No. of
petri dish

CHX

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

21.2
21.8
23.5
21.7
21.7
21.3
20.0
20.3
22.2
19.4
19.5
19.4
19.7
19.4
22.0
19.6
21.7
21.8
20.0
20.8

Short
30.3
31.0
33.8
29.7
31.9
31.3
25.6
28.6
32.6
28.2
26.5
24.5
29.8
28.8
31.2
18.8
32.0
29.7
23.5
32.1

Diameter
OzOO
Long
Mean
38.6
34.5
41.5
36.3
47.1
40.5
39.2
34.5
47.6
39.8
41.2
26.3
29.1
27.4
29.3
29.0
25.9
34.3
31.3
29.8
28.1
27.3
25.9
25.2
32.4
31.1
29.6
29.2
31.7
31.5
18.8
18.8
33.6
32.8
31.6
30.7
32.3
27.9
32.1
32.1
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Olive oil
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Normal
saline
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Table 2. Diameters in millimeters of the growth inhibition zone for OzOO, CHX,
olive oil and normal saline against A. actinomycetemcomitans
No. of
petri
dish
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18

CHX

Short
26.7
24.1
26.1
27.8
26.9
24.5
27.2
27.9
20.9
22.1
25.0
22.1
24.5
26.2
27.0
24.0
24.6
22.1

19.1
20.0
18.9
19.9
18.4
20.0
20.9
18.9
17.2
18.2
17.8
18.5
18.2
20.1
15.8
15.6
18.1
15.8

Diameter
OzOO
Long
Mean
26.7
26.7
24.1
24.1
26.1
26.1
27.8
27.8
26.9
26.9
24.5
24.5
27.2
27.2
27.9
27.9
21.4
21.2
29.0
25.6
27.3
26.2
25.8
24.0
26.6
25.6
28.0
27.1
27.0
27.0
25.6
24.8
28
26.3
32.5
27.3

Olive oil
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Normal
saline
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Table 3. Mean diameter and SD of the growth inhibition zone for OzOO, CHX, olive
oil and normal saline against P. gingivalis and A. actinomycetemcomitans
Antiseptic
CHX
OzOO
Olive oil
Normal
saline

P. gingivalis
Mean
SD
20.9
1.19
31.4
5.05
6
0
6

0
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A. actinomycetemcomitans
Mean
SD
18.4
1.55
25.9
1.69
6
0
6

0

Figure 3. Bar chart of the mean diameter of the growth inhibition zone with
error bars representing SD for OzOO and CHX against P. gingivalis and A.
actinomycetemcomitans
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Figure 4. Box-and-whisker plot of the mean diameter of the growth inhibition
zone with median, 25% and 75% quartiles, and, minimum and maximum for
OzOO, CHX, olive oil and normal saline against P. gingivalis and A.
actinomycetemcomitans
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Figure 5. Petri dish (dish no. 12) for P. gingivalis, upper left quadrant – sterile
disk impregnated by normal saline, upper right quadrant – sterile disk
impregnated by CHX, lower right quadrant – sterile disk impregnated by olive oil,
lower left quadrant – sterile disk impregnated by OzOO
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Figure 6. Petri dish (dish no. 12) for P. gingivalis, for measuring the diameter,
upper left quadrant – sterile disk impregnated by CHX, upper right quadrant –
sterile disk impregnated by normal saline, lower right quadrant – sterile disk
impregnated by OzOO, lower left quadrant – sterile disk impregnated by olive oil
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Figure 7. Petri dish (dish no. 12) for A. Actinomycetemcomitans, upper left
quadrant – sterile disk impregnated by normal saline, upper right quadrant –
sterile disk impregnated by CHX, lower right quadrant – sterile disk impregnated
by olive oil, lower left quadrant – sterile disk impregnated by OzOO
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Figure 8. Petri dish (dish no. 15) for A. Actinomycetemcomitans, upper left
quadrant – sterile disk impregnated by normal saline, upper right quadrant –
sterile disk impregnated by CHX, lower right quadrant – sterile disk impregnated
by olive oil, lower left quadrant – sterile disk impregnated by OzOO
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Table 4. Paired sample t-test to compare the antibacterial activity of OzOO and CHX
against P. gingivalis and A. actinomycetemcomitans

Bacteria
P. gingivalis
A.
actinomycetmocomitans

Pair
OzOO CHX
OzOO CHX

Mean

SD

SE

95% Confidence
Interval of the
Difference

Lower

Upper

t

df

Sig
(2-tailed)

10.6

4.19

0.94

8.61

12.53

11.30

19

.000

7.5

2.12

0.50

6.43

8.53

14.97

17

.000
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CHAPTER FOUR
DISCUSSION
Comparing the diameters of the growth inhibition zone for CHX and OzOO
against P. gingivalis and A. actinomycetemcomitans, the antibacterial activity of
OzOO was greater than that of CHX with a statistical significance (p<0.001). Based
on the results, this study indicates that OzOO may be an alternative to CHX as an
antiseptic agent.
Two important findings should be considered in this study. At first, the shape
of the growth inhibition zone of OzOO against both microbials was not always a full
circle. The possible reason is the uneven and/or incomplete distribution of OzOO
into the sterile disk during the disk impregnation period resulting in uneven
distribution of OzOO into microbial suspensions during the incubation period. In
addition, when semi solid-liquid OzOO was warmed up in the heating bath circulator
to be converted into liquid for disk impregnation, the amount of peroxide can be
potentially lost. The second noticeable finding was the fully and/or partially blurred
growth inhibition zone for OzOO and CHX against A. actinomycetemcomitans, being
interpreted as the partial antibacterial activity. It is difficult to compare the degree
of partial antibacterial activity, because the degree of blurring was different. The
degree of blurring for OzOO varied between petri dishes. It was also different from
the degree of blurring for CHX. The growth inhibition zone for CHX was a clear circle
with a blurred edge. The possible reasons of the blurred growth inhibition zone are
the potential regrowth of A. actinomycetemcomitans during the incubation period
and non-purified A. actinomycetemcomitans itself.
18

There are various methods to evaluate the antibacterial activity; diffusion
method, dilution method, thin-layer chromatography bioautography, time-kill test,
ATP bioluminescence assay and flow cytofluorometric method (22, 23). Disk
diffusion susceptibility test, one of the diffusion methods, was used in this in vitro
study. Disk diffusion susceptibility test assesses the antimicrobial activity by
measuring the diameters of the growth inhibition zone surrounding each disk with a
caliper in millimeters. This test is widely used because of its simplicity, easy
interpretation, flexibility in disk selection and low cost, though it is lacking
mechanization or automatization. For the interpretation of the test, the result can be
analyzed in two ways, both qualitatively and quantitatively. By the CLSI guideline
(Clinical and Laboratory Standards Institute, formerly National committee for
Clinical Laboratory Standards, NCCLS), there are 3 categories, susceptible,
intermediate or resistant based on the standard diameter of each antibiotic for the
qualitative interpretation (24). However, the qualitative interpretation from the
result of this in vitro study was difficult because CLSI guideline doesn’t give any
information about OzOO and CHX, used in this study. Minimal inhibitory
concentration (MIC) is evaluated for the quantitative interpretation. However,
determining the exact MIC is not appropriate through disk diffusion susceptibility
test, because it is difficult to quantify the amount of diffused antimicrobial agent.
Therefore, in this in vitro study, only the diameter of the growth inhibition zone was
compared to evaluate the antibacterial activity.
In the consensus report from the World Workshop of Periodontology, P.
gingivalis, A. actinomycetemcomitans and T. forsythia are considered to play the
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major role in developing periodontal disease (2). As one of the red complex bacteria,
P. gingivalis, Gram-negative anaerobic and non-motile rod, is elevated in the active
lesions of destructive periodontal disease (2). A. actinomycetemcomitans, Gramnegative facultative anaerobic and non-motile rod, is an important virulence factor
in the pathogenesis of aggressive periodontitis with highly leukotoxic effects (25).
Related to these bacterial species, periodontal disease, also being affected by other
co-factors, is developed and destructing peridontium.
To control periodontal disease, non-surgical treatment is usually performed
to eliminate oral pathogens mechanically. Based on the series of studies, SRP
favorably improved pocket depth (PD) and clinical attachment level (CAL) for both
moderate and advanced periodontitis (26, 27). Microbiologically, SRP also reduced
the amount of various bacterial species related to periodontal disease though they
were still remained to some extent (28, 29). Therefore, 0.2% CHX mouthrinse was
used following SRP for treating periodontitis and, it improved both PD and CAL in all
initially different PD groups (14). Plus, CHX itself was also effective to reduce plaque
index and gingival index in addition to the oral hygiene, toothbrushing and
interdental cleansing (10).
A new OzOO for tooth and gum support (PurO3™) is now available in the
field of dentistry as an alternative to CHX with fewer side effects. OzOO is basically
produced through the chemical reaction between ozone and olive oil. When ozone,
activated oxygen, is funneled into a tube, an electrical charge is generated. During
this process, ozone is slowly infused into olive oil and OzOO is created. For the
physiochemical property, there is a chemical reaction, called ozonolysis, between
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ozone and unsaturated fatty acid of olive oil, especially alkene (carbon-to-carbon
double bonds) in fatty acid (19). In PurO3™, 224 meq/Kg of hydrogen peroxide is
formed as a result of ozonolysis. In another study showing significant growth
inhibition against P. gingivalis and S. aureus by OzOO (Novox® , MoSS, Italy), 560590 meq/Kg of hydrogen peroxide was formed by ozonolysis in OzOO (21).
Regarding to the safety of ozone as an alternative antiseptic, it is important to
understand the potential toxic effects of ozone. According to studies evaluating the
cytotoxic effects of gaseous and aqueous ozone, aqueous ozone proved the highest
level of biocompatibility on oral epithelial cells, gingival fibroblasts and periodontal
cells (30, 31).
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CHAPTER FIVE
CONCLUSION
Within the limits of this study, it is concluded that the antibacterial activity of
OzOO against P. gingivalis and A. actinomycetemcomitans is superior to that of CHX.
For the clinical use of OzOO as an alternative to CHX, other research such as in vivo
and clinical study should be designed and planned.
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